Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-PSMA PET-MRI for Mapping Prostate Cancer
NCT04461509Phase 2Terminated
- Start
- Apr 2021
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 18F-PSMA in prostate cancer (PCa). Started Apr 2021; status: terminated.
02
Drugs
18F-PSMA
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04461509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04461509.